Probiotics Can Help Improve Gut Permeability and Reduce Systemic Inflammation, Study Finds

Probiotics Can Help Improve Gut Permeability and Reduce Systemic Inflammation, Study Finds
A combination of five probiotic bacteria strains in a “spore-based” formulation marketed by Microbiome Labs under the name MegaSporeBiotic reduced inflammation and endotoxin levels commonly associated with “leaky bowel” symptoms, according to a recent study. These findings, “Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers” were published in The World Journal of Gastrointestinal Pathophysiology. Leaky bowel is increasingly recognized as a first insult that may lead to a series of conditions, such as inflammatory bowel disease (IBD). “To our knowledge, the present study is the first attempt to clinically leverage the benefits of spore-based probiotics to improve health outcomes,” Brian K McFarlin, PhD, associate professor at the University of North Texas, and colleagues wrote on their report. Diets rich in highly processed and calorie-dense foods, combined with reduced physical activity, probably have contributed greatly to the development of several chronic illnesses associated with gastrointestinal tract abnormalities and systemic inflammation. Although not recognized as a medical condition, the “leaky bowel” is characterized by impaired gut barrier function. With no specific tests to identify this situation, researchers have proposed the analysis of metabolic endotoxins
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *